MedPath

ACTAVIS PHARMA, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

203

FDA:203

Drug Approvals

Nabumetone

Approval Date
Jul 7, 2025
FDA

Matzim LA

Approval Date
May 1, 2025
FDA

Chlorzoxazone

Approval Date
Aug 25, 2024
FDA

Atenolol and Chlorthalidone

Approval Date
Mar 29, 2024
FDA

Layolis Fe

Approval Date
Mar 22, 2024
FDA

Minoxidil

Approval Date
Feb 16, 2024
FDA

Buprenorphine and Naloxone

Approval Date
Jan 24, 2024
FDA

Deferasirox

Approval Date
Jan 17, 2024
FDA

Ondansetron

Approval Date
Jan 16, 2024
FDA

Buprenorphine

Approval Date
Jan 1, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.